# OnCo record b-survivorship (bottleneck). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/bottlenecks/b-survivorship/>
  a schema:Thing ;
  onco:kind "bottleneck" ;
  schema:identifier "b-survivorship" ;
  schema:name "Survivorship and late effects are neglected"@en ;
  schema:description "Tens of millions of people live after cancer with heart damage, infertility, second cancers and fear, and few services."@en ;
  schema:url <https://onco.cc/bottlenecks/b-survivorship/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://cancercontrol.cancer.gov/ocs/statistics>, <https://doi.org/10.1056/NEJMsa060185>, <http://www.survivorshipguidelines.org/>, <https://ccss.stjude.org/> ;
  onco:related <https://onco.cc/collections/seer/>, <https://onco.cc/ideas/idea-exercise-as-adjuvant/>, <https://onco.cc/ideas/idea-acc-auto-generated-survivorship-plans/>, <https://onco.cc/ideas/idea-acc-risk-stratified-cardio-oncology-pathway/>, <https://onco.cc/ideas/idea-acc-default-fertility-preservation-referral/>, <https://onco.cc/ideas/idea-acc-national-late-effects-registry/>, <https://onco.cc/ideas/idea-acc-tailored-second-cancer-screening/>, <https://onco.cc/ideas/idea-acc-return-to-work-rehabilitation/>, <https://onco.cc/ideas/idea-acc-cognitive-rehabilitation-after-chemotherapy/>, <https://onco.cc/ideas/idea-acc-cardiometabolic-clinic-hormone-therapy/>, <https://onco.cc/ideas/idea-acc-aya-survivorship-passport/>, <https://onco.cc/ideas/idea-acc-survivor-biobank-late-effect-prediction/>, <https://onco.cc/ideas/idea-acc-lymphoedema-prospective-surveillance/>, <https://onco.cc/ideas/idea-moon-survivor-lifelong-care-model/> ;
  onco:cancers <https://onco.cc/cancers/hodgkin-lymphoma/>, <https://onco.cc/cancers/all-leukemia/>, <https://onco.cc/cancers/neuroblastoma/>, <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/breast-her2-positive/>, <https://onco.cc/cancers/thyroid/>, <https://onco.cc/cancers/prostate/> ;
  onco:sections <https://onco.cc/fronts/supportive-care/> ;
  onco:technologies <https://onco.cc/technologies/cardio-oncology/>, <https://onco.cc/technologies/exercise-oncology/>, <https://onco.cc/technologies/scalp-cooling/>, <https://onco.cc/technologies/fertility-sparing-endometrial/> ;
  onco:companies <https://onco.cc/companies/childrens-oncology-group/> ;
  onco:institutions <https://onco.cc/institutions/nci/>, <https://onco.cc/institutions/asco/> ;
  onco:terms <https://onco.cc/terms/trastuzumab-cardiotoxicity/>, <https://onco.cc/terms/late-recurrence/>, <https://onco.cc/terms/tsh-suppression/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-oeffinger-n-engl-j-med/> .